Skip to main content

Table 3 Multivariate analysis of factors associated with OS and DFS in all surgical patients

From: Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases

OS HR 95 % CI p
Age >65 years 5.90 2.57–14.5 <0.001
Male 1.12 0.52–2.62 0.780
Synchronous disease 2.85 1.28–7.03 0.009
DFS HR 95 % CI p
Synchronous disease 1.08 0.57–2.05 0.809
Conversion disease 1.32 0.59–2.90 0.491
No. of liver metastases ≥5 1.68 0.85–3.26 0.137
Maximum tumor size >5 cm 1.59 0.80–3.02 0.179
  1. OS overall survival, DFS disease-free survival, HR hazard ratio, CI confidence interval